Thus far,only a handful of broadly reactive human neutralizing monoclonal antibodies (nmAbs) have beendescribed, all of which were derived from HIV clade B-infected individuals. The overall goal of Project 2 is toexploit the broadly reactive neutralizing antibody (nAb) responses we have observed in some of theexperimental monkeys infected with and/or vaccinated against simian-human immunodeficiency virus(SHIV) strains that encode primary R5 env genes of pediatric HIV clade C isolates from Zambia. Under thecurrent HIVRAD, which is under no-cost extension, we have identified monkey sera that not only neutralizehomologous SHIV clade C and the corresponding parental HIV clade C, but also heterologous HIV clade Cas well as non-related HIV clade B strains. The neutralizing activity was shown to be mediated by IgG inseveral animals. Our experimental rhesus monkeys with cross-reactive nAb responses represent a valuable esource, and this proposal seeks to further identify the nature of the anti-HIV clade C Env nAbs that havedeveloped. We hypothesize that some nAbs in these sera recognize conserved structures within HIVEnv,and we thus seek to develop novel nmAbs and to identify novel mimotopes.
The Specific Aims of this proposalare:1. To isolate nmAbs from B cells collected from monkeys with IgG nAbs that block HIV infection with bothHIV clade C and B isolates.2. To characterize the epitope specificity of the new anti-HIV clade C nmAbs and to test whether theydisplay autoreactivity.3. To use the phage display technology in conjunction with a novel computer-based analysis, termed 3DEX,to identify conformational mimotopes that mimic the epitopes of the novel anti-HIV clade envelope mAbs. Ina parallel, independent approach, the phage display/3DEX strategy will also be used directly with polyclonalnAbs from the monkeys.By dissecting the nature of the cross-clade nAbs, we may uncover new HIV Env targets and our strategymay thus have a high impact on the development of anti-HIV clade C vaccines that seek to induce nAbresponses.
Showing the most recent 10 out of 77 publications
